Focused ultrasound is being used to deliver gene therapy across the blood-brain barrier to restore nerve pathways damaged in Parkinson’s disease. This groundbreaking work is rapidly becoming a promising option for potentially curing the disabling disease.
The Foundation is proud to be part of the emerging field of focused ultrasound for immune-based cancer treatment. “Wear White” on June 14 for a future immune to cancer.
Foundation Council member and co-chair, Mrs. Jane P. Batten, was awarded an honorary degree at the 2019 William & Mary commencement ceremony. Watch to learn more about Mrs. Batten’s philanthropic activities, including her dedication to education and the environment.
Insightec announced that their Exablate Neuro treatment for essential tremor will now be reimbursed in Japan, where nine medical centers are currently offering the treatment.
Thomas was treated with high intensity focused ultrasound therapy for prostate cancer. He flew to Washington, DC, to tell representatives about the treatment’s effectiveness.
After being diagnosed with ALS, Hanna volunteered to receive focused ultrasound therapy to open the blood-brain barrier over the motor cortex at Sunnybrook.
The National Institute of Neurological Disorders and Stroke awarded a $2.5 million research grant to Rich Price, PhD, and Jung Soo Suk, PhD, for their gene therapy project.
Researchers at Stanford University sought to develop a system that could precisely predict focal spot heating during focused ultrasound brain treatment.
The annual meeting of the Society for Thermal Medicine was held April 28 – May 2 in Florida. Eight international research groups presented focused ultrasound abstracts.
Could focused ultrasound become the first-line treatment for children with osteoid osteoma? Data from three international university hospitals provide initial evidence.
The US Food and Drug Administration held an interactive workshop with regulatory experts, creating understanding for drug and medical device regulatory requirements.
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
